Third Security’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-134
Closed -$66K 17
2020
Q2
$66K Hold
134
0.01% 12
2020
Q1
$49K Buy
+134
New +$69.3K 0.01% 11
2019
Q1
Sell
-29,094
Closed -$8.16M 15
2018
Q4
$8.16M Sell
29,094
-35,637
-55% -$14.1M 1.11% 6
2018
Q3
$31.1M Hold
64,731
2.02% 4
2018
Q2
$29.3M Hold
64,731
2.36% 4
2018
Q1
$38.1M Hold
64,731
2.76% 3
2017
Q4
$40.2M Hold
64,731
3.45% 3
2017
Q3
$59.6M Hold
64,731
3.76% 3
2017
Q2
$60.4M Hold
64,731
3.07% 3
2017
Q1
$61.6M Hold
64,731
3.6% 4
2016
Q4
$51.9M Buy
64,731
+115
+0.2% +$104K 2.8% 3
2016
Q3
$54.6M Hold
64,616
2.54% 3
2016
Q2
$53.2M Hold
64,616
2.77% 3
2016
Q1
$71.9M Hold
64,616
2.81% 3
2015
Q4
$80.5M Buy
64,616
+178
+0.3% +$294K 3.22% 3
2015
Q3
$87.1M Hold
64,438
3.46% 3
2015
Q2
$116M Sell
64,438
-64,045
-50% -$99.4M 3.03% 3
2015
Q1
$208M Buy
128,483
+9,600
+8% +$14.2M 5.84% 3
2014
Q4
$90.4M Buy
118,883
+112
+0.1% +$59.5K 4.13% 3
2014
Q3
$47M Hold
118,771
2.93% 3
2014
Q2
$71.8M Hold
118,771
3.42% 3
2014
Q1
$81.6M Hold
118,771
3.62% 3
2013
Q4
$77.3M Buy
118,771
+19,173
+19% +$11.4M 3.68% 3
2013
Q3
$58.9M Hold
99,598
2.99% 3
2013
Q2
$31.5M Buy
+99,598
New +$27.7M 7.54% 3

Other funds holding TCRT

Third Security's TCRT Position: Q3 2020 in Review

Third Security sold out of Alaunos Therapeutics (TCRT) in Q3 2020, closing a stake of 134 shares — an estimated $66K sold.

Third Security first reported a position in TCRT in Q2 2013 and held it in 25 quarters. The position peaked at $208M in Q1 2015. 154 funds tracked by Wall St. Rank hold TCRT as of Q3 2020.

  • Third Security reported no remaining Alaunos Therapeutics position as of Q3 2020 after selling out during the quarter.
  • Third Security sold 134 Alaunos Therapeutics shares in Q3 2020, an estimated $66K.
  • Third Security first reported a position in Alaunos Therapeutics in Q2 2013 and held it in 25 quarters.
  • Third Security's Alaunos Therapeutics position peaked at $208M in Q1 2015.
  • 154 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2020.

Based on Third Security's 13F filing for Q3 2020, filed 16 Nov 2020.